A cardiologist view of vascular disease in diabetes

Christopher J Lockhart1, Paul K Hamilton, Katherine A McVeigh

  • 1Department of Therapeutics and Pharmacology, School of Medicine, Queens university, Belfast, UK.

Insights

Diabetes significantly increases cardiovascular risks, leading to higher mortality and complications like heart failure and stroke. Aggressive management of risk factors and targeted therapies are crucial for preventing vascular events in diabetic patients.

Area of Science:

  • Cardiology
  • Endocrinology
  • Vascular Biology

Background:

  • Diabetes mellitus is a major risk factor for diverse cardiovascular (CV) complications.
  • Diabetic metabolic changes disrupt vascular health, increasing end-organ damage and CV events.
  • Diabetic patients face higher mortality from acute coronary syndromes and increased risk of heart failure, stroke, and peripheral vascular disease.

Purpose of the Study:

  • To outline the significant cardiovascular risks associated with diabetes mellitus.
  • To emphasize the importance of aggressive risk factor management and targeted therapies in diabetic patients.
  • To highlight the need for improved understanding of vascular biology for novel therapeutic development.

Main Methods:

  • Review of existing literature on diabetes and cardiovascular complications.
  • Analysis of the impact of diabetes on blood rheology, arterial structure, and endothelial function.
  • Discussion of current therapeutic strategies including risk factor control, medical therapy, and revascularization.

Main Results:

  • Diabetes significantly elevates the risk of acute coronary syndromes, chronic cardiac failure, stroke, renal failure, and peripheral vascular disease.
  • Aggressive management of blood glucose, lipids, and blood pressure is essential for optimal cardiac care.
  • Medical therapies targeting plaque stability and platelet activity reduce event frequency.

Conclusions:

  • Preventing vascular events is the primary therapeutic goal for patients with diabetes.
  • Comprehensive management including risk factor control, targeted medications, and revascularization is necessary.
  • Further research into vascular biology is critical for developing new treatments to improve outcomes in diabetic patients.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...